- Corporate Officers - K
- Kalowski Lee
Insider Trading History of Kalowski Lee
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kalowski Lee since 2015.
This trader's CIK number is 1618273.
At the time of last reporting, Kalowski Lee was the CFO and President of Q32 Bio Inc.. (stock ticker symbol QTTB).
Also see all insider trading activities at Q32 Bio Inc..
Note that in the past
Kalowski Lee also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Q32 Bio Inc. (QTTB) by Kalowski Lee
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | QTTB | 0 | $0 | 4,240 | $7,636 | 0 | $0 |
Yearly summary of insider trading at Eledon Pharmaceuticals, Inc. (TKAI) by Kalowski Lee
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | TKAI | 0 | $0 | 13,651 | $174,482 | 0 | $0 |
Yearly summary of insider trading at Bicycle Therapeutics Plc (BCYC) by Kalowski Lee
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | BCYC | 0 | $0 | 2,191 | $60,680 | 0 | $0 |
| 2021 | BCYC | 0 | $0 | 63,500 | $2,047,114 | 63,500 | $244,646 |
| 2020 | BCYC | 0 | $0 | 35,000 | $721,152 | 35,000 | $54,598 |
Insider trading activities at 3 companies by Kalowski Lee:
1. Q32 Bio Inc. (QTTB)
2. Eledon Pharmaceuticals, Inc. (TKAI)
3. Bicycle Therapeutics Plc (BCYC)
Table 1. Insider trading of Q32 Bio Inc. (QTTB) by Kalowski Lee
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-26 | QTTB | Sale | 4,240 | 1.80 | 7,636 |
Table 2. Insider trading of Eledon Pharmaceuticals, Inc. (TKAI) by Kalowski Lee
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-09-08 | TKAI | Sale | 4,668 | 13.13 | 61,290 |
| 2015-09-02 | TKAI | Sale | 2,158 | 12.96 | 27,967 |
| 2015-04-16 | TKAI | Sale | 4,567 | 13.00 | 59,371 |
| 2015-04-02 | TKAI | Sale | 2,258 | 11.45 | 25,854 |
Table 3. Insider trading of Bicycle Therapeutics Plc (BCYC) by Kalowski Lee
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-04-03 | BCYC | Sale | 376 | 21.11 | 7,937 |
| 2023-01-03 | BCYC | Sale | 1,815 | 29.06 | 52,743 |
| 2021-09-02 | BCYC | Option Ex | 10,000 | 9.82 | 98,200 |
| 2021-09-02 | BCYC | Sale | 10,000 | 40.00 | 400,000 |
| 2021-08-27 | BCYC | Sale | 7,950 | 35.15 | 279,442 |
| 2021-08-26 | BCYC | Sale | 550 | 35.04 | 19,272 |
| 2021-08-27 | BCYC | Option Ex | 7,950 | 8.73 | 69,403 |
| 2021-08-26 | BCYC | Option Ex | 550 | 8.76 | 4,818 |
| 2021-08-23 | BCYC | Option Ex | 7,500 | 1.60 | 12,000 |
| 2021-08-23 | BCYC | Sale | 7,500 | 33.02 | 247,650 |
| 2021-07-29 | BCYC | Option Ex | 12,500 | 1.63 | 20,375 |
| 2021-07-29 | BCYC | Sale | 12,500 | 32.06 | 400,750 |
| 2021-01-19 | BCYC | Sale | 15,000 | 30.00 | 450,000 |
| 2021-01-19 | BCYC | Option Ex | 15,000 | 1.59 | 23,850 |
| 2021-01-14 | BCYC | Option Ex | 10,000 | 1.60 | 16,000 |
| 2021-01-14 | BCYC | Sale | 10,000 | 25.00 | 250,000 |
| 2020-12-01 | BCYC | Option Ex | 7,500 | 1.56 | 11,700 |
| 2020-12-01 | BCYC | Sale | 7,500 | 22.50 | 168,750 |
| 2020-11-27 | BCYC | Option Ex | 530 | 1.56 | 826 |
| 2020-11-27 | BCYC | Sale | 530 | 20.00 | 10,600 |
| 2020-11-25 | BCYC | Sale | 9,781 | 20.07 | 196,304 |
| 2020-11-25 | BCYC | Option Ex | 9,781 | 1.56 | 15,258 |
| 2020-11-23 | BCYC | Sale | 17,189 | 20.10 | 345,498 |
| 2020-11-23 | BCYC | Option Ex | 17,189 | 1.56 | 26,814 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kalowski Lee
(CFO and President of Q32 Bio Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.